COMP <GO>
COCH vs APT // RSI-14 & 200D SMA MOMENTUM
Envoy Medical Inc. (Class A) (NASDAQ) VS. Alpha Pro Tech Ltd. (NYSE) • 15-METRIC TALLY: COCH 1
— APT 7
▲ RSI-14 & 200D SMA MOMENTUM LEADER: APT
LAST: $6.63 (+2.00%) • MKT CAP: $50.3M
rsi-technicals
47.9
LAST: $5.40 (-2.70%) • MKT CAP: $56.6M
rsi-technicals
52.2
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COCH VS. APT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | COCH | APT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -30.00% | 38.10% | -68.10 | APT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 6.70% | -41.70 | APT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 9.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 3.06% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 6.50% | -66.50 | APT | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 5.90% | -65.90 | APT | /net-margins <GO> |
| Revenue Growth (YoY) | 7.10% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.62% | 0.00% | +3.62 | COCH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.59 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 5/9 | -3.00 | APT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 47.9 | 52.2 | -4.30 | APT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 15.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $50.3M | $56.6M | -$6.3M | APT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | COCH REV | APT REV | COCH GROSS % | APT GROSS % | COCH FCF | APT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $241.0K | $59.1M | -50.0% | 38.1% | -$18.4M | $1.7M |
| FY 2024 | $225.0K | $57.8M | -50.0% | 39.6% | -$18.9M | $1.9M |
| FY 2023 | $316.0K | $0 | — | — | -$17.1M | $8.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COCH // BETA —
APT // BETA —